IL162158A0 - Prodrugs to d-prolines - Google Patents

Prodrugs to d-prolines

Info

Publication number
IL162158A0
IL162158A0 IL16215802A IL16215802A IL162158A0 IL 162158 A0 IL162158 A0 IL 162158A0 IL 16215802 A IL16215802 A IL 16215802A IL 16215802 A IL16215802 A IL 16215802A IL 162158 A0 IL162158 A0 IL 162158A0
Authority
IL
Israel
Prior art keywords
prolines
prodrugs
Prior art date
Application number
IL16215802A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL162158A0 publication Critical patent/IL162158A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16215802A 2001-12-14 2002-12-06 Prodrugs to d-prolines IL162158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129793 2001-12-14
PCT/EP2002/013827 WO2003051836A1 (en) 2001-12-14 2002-12-06 Prodrugs to d-prolines

Publications (1)

Publication Number Publication Date
IL162158A0 true IL162158A0 (en) 2005-11-20

Family

ID=8179542

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16215802A IL162158A0 (en) 2001-12-14 2002-12-06 Prodrugs to d-prolines
IL162158A IL162158A (en) 2001-12-14 2004-05-24 Prodrugs to d-prolines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162158A IL162158A (en) 2001-12-14 2004-05-24 Prodrugs to d-prolines

Country Status (26)

Country Link
US (1) US6903129B2 (zh)
EP (2) EP1458680A1 (zh)
JP (1) JP4192100B2 (zh)
KR (1) KR100678785B1 (zh)
CN (1) CN100368397C (zh)
AR (1) AR038010A1 (zh)
AU (1) AU2002361982B2 (zh)
BR (1) BR0214932A (zh)
CA (1) CA2470037C (zh)
GT (1) GT200200275A (zh)
HK (1) HK1076100A1 (zh)
HR (1) HRP20040494A2 (zh)
HU (1) HUP0402600A3 (zh)
IL (2) IL162158A0 (zh)
MX (1) MXPA04005693A (zh)
MY (1) MY129431A (zh)
NO (1) NO20042979L (zh)
NZ (1) NZ533188A (zh)
PA (1) PA8561201A1 (zh)
PE (1) PE20030764A1 (zh)
PL (1) PL370803A1 (zh)
RU (1) RU2305679C2 (zh)
TW (1) TWI225400B (zh)
UY (1) UY27584A1 (zh)
WO (1) WO2003051836A1 (zh)
ZA (1) ZA200404546B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313386D0 (en) * 2003-06-10 2003-07-16 Univ London Treatment of disease
UA108227C2 (xx) 2010-03-03 2015-04-10 Антигензв'язуючий білок
RU2530601C2 (ru) * 2012-10-05 2014-10-10 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Ингибитор образования цинк-зависимых димеров бета-амилоида
GB201407506D0 (en) 2014-04-29 2014-06-11 Glaxosmithkline Ip Dev Ltd Novel compound
US9737505B2 (en) 2014-04-29 2017-08-22 Glaxosmithkline Intellectual Property Development Limited Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
GB201518950D0 (en) * 2015-10-27 2015-12-09 Glaxosmithkline Ip Dev Ltd Compound
WO2017072090A1 (en) * 2015-10-27 2017-05-04 Glaxosmithkline Intellectual Property Development Limited Combination therapy
GB202111866D0 (en) 2021-08-18 2021-09-29 Ucl Business Plc Prodrugs for use in the treatment of tissue damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112778A0 (en) 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
PT915088E (pt) * 1997-10-31 2003-01-31 Hoffmann La Roche Derivados de d-prolina

Also Published As

Publication number Publication date
AR038010A1 (es) 2004-12-22
AU2002361982A1 (en) 2003-06-30
GT200200275A (es) 2003-07-30
US6903129B2 (en) 2005-06-07
BR0214932A (pt) 2004-11-30
EP1458680A1 (en) 2004-09-22
AU2002361982B2 (en) 2008-09-25
MXPA04005693A (es) 2004-12-06
US20030134891A1 (en) 2003-07-17
KR100678785B1 (ko) 2007-02-05
CN100368397C (zh) 2008-02-13
IL162158A (en) 2010-11-30
NZ533188A (en) 2006-07-28
HRP20040494A2 (en) 2005-12-31
MY129431A (en) 2007-03-30
ZA200404546B (en) 2006-02-22
CN1604892A (zh) 2005-04-06
JP4192100B2 (ja) 2008-12-03
PL370803A1 (en) 2005-05-30
KR20040063992A (ko) 2004-07-15
UY27584A1 (es) 2003-07-31
RU2004121783A (ru) 2005-05-10
JP2005515211A (ja) 2005-05-26
WO2003051836A1 (en) 2003-06-26
NO20042979L (no) 2004-07-13
CA2470037A1 (en) 2003-06-26
HUP0402600A2 (hu) 2005-03-29
EP1743884A1 (en) 2007-01-17
RU2305679C2 (ru) 2007-09-10
HK1076100A1 (en) 2006-01-06
PE20030764A1 (es) 2003-09-11
CA2470037C (en) 2011-06-14
TWI225400B (en) 2004-12-21
TW200409626A (en) 2004-06-16
PA8561201A1 (es) 2004-03-26
HUP0402600A3 (en) 2011-05-30

Similar Documents

Publication Publication Date Title
IL151073A0 (en) Antiviral prodrugs
GB0106247D0 (en) Improvements relating to supports
GB0306907D0 (en) Boireductively-activated prodrugs
EP1511408A4 (en) BACKPACK WITH WHEELS
AU2002359659A8 (en) Cross reference to related application
AU2002360487A8 (en) Acyclovir-peptide analogs
HK1076100A1 (en) Prodrugs to d-prolines
GB0113124D0 (en) Improvements relating to cartons
EP1343494A4 (en) PROMOTERS TETRAPARTATES
EP1585750A4 (en) NARCISTATIN-BASED PRODRUGS
GB0117171D0 (en) Plant
GB0028814D0 (en) Improvements relating to biosorbtion
GB0112902D0 (en) Improvement to tyres
HRP20030897A2 (en) Plant invigorator
GB2377666B (en) Improvements to wrenches
GB0108110D0 (en) Keeps
SI1261613T1 (en) Gastro-specific prodrugs
GB0125819D0 (en) Improvements to flooring
GB0029608D0 (en) Improvements relating to lamp-holder
GB0108925D0 (en) Improvements relating to supports
GB0117022D0 (en) Improvements relating to gears
GB0103333D0 (en) Improvements on or telating to stairlifts
GB2382359B (en) Structural elongate elements
GB0200903D0 (en) Improvements relating to entertainment
GB0025715D0 (en) Improvements relating to haribrushes